Table 1.
Association between baseline clinical characteristics with patients’ disease type for Moffitt TCC data.
| Variable | Metastatic | Primary | P-value |
|---|---|---|---|
| N = 29 | N = 194 | ||
| Age at diagnosis (years) <64 Years | 8 (27.6%) | 130 (67.0%) | 0.014 |
| > = 64 Year | 13 (44.8%) | 63 (32.5%) | |
| missing | 8 (27.6%) | 1 (0.5%) | |
| Gleason Score 5–6 | — | 64 (33.0%) | |
| 7 | — | 125 (64.4%) | |
| 8–10 | — | 3 (1.5%) | |
| Missing | — | 2 (1.0%) | |
| Clinical Tumor Stage T1A,T1C | — | 152 (78.4%) | |
| T2,T2A,T2B,T2C | — | 37 (19.1%) | |
| Missing | — | 5 (2.6%) | |
| Lymph node involvement | 0.023 | ||
| N1 | 1 (3.4%) | 1 (0.5%) | |
| N0 | 1 (3.4%) | 172 (88.6%) | |
| Missing | 27 (93.1%) | 21 (10.8%) | |
| Margin Status Negative | — | 144 (74.2%) | |
| Positive | — | 49 (25.3%) | |
| Missing | — | 1 (0.52%) | |
| Hormone(second course) | <0.001 | ||
| No | 0 (0%) | 186 (96.4%) | |
| Yes | 5 (17.2%) | 7 (3.6%) | |
| Missing | 24 (82.8%) | 1 (0.5%) |
*P-values for categorical variables calculated using the Fisher’s Exact method.